terlipressin 0.85 MG Injection
- RxCUI
- 2612431
- RxNorm name
- terlipressin 0.85 MG Injection
- Display name
- terlipressin 0.85 MG Injection
- Full name
- terlipressin 0.85 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terlivaz | TERLIPRESSIN | Mallinckrodt Hospital Products Inc. | 3a35b86c-f451-4fac-8499-43019e4da354 | 2026-06-19 | Boxed warning, Warnings, Adverse reactions | 2612431 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3a35b86c-f451-4fac-8499-43019e4da354 | terlipressin 0.85 MG Injection [PSN] · terlipressin 0.85 MG Injection [SCD] | 2 | 6 | These highlights do not include all the information needed to use TERLIVAZ ® safely and effectively. See full prescribing information for TERLIVAZ. TERLIVAZ (terlipressin) for injection, for intravenous use Initial U.S. Approval: 2022 | 20251111 |